Functional Recovery Effect of Bloodletting Puncture at Jing-well Points on Acute Brain Injury Patients
To Evaluate the Functional Recovery Effect of Bloodletting Puncture at Jing-well Points on Acute Brain Injury Patients
1 other identifier
interventional
72
1 country
1
Brief Summary
Traumatic brain injury (Traumatic brain injury, TBI) can be derived from various forms of injury, including blunt trauma, penetrating or acceleration/deceleration force caused by head injury.There are some study data show that acupuncture treatment has a superficial effect on the prognosis of traumatic brain injury and can limit the progression of secondary brain injury, but the effect of early bloodletting at the Jing-points on TBI patients still unknown. In our study, the investigators have proposed a randomized, controlled study design and plan to evaluate the efficacy and safety of Jing-point puncture to improve consciousness and neurological function in patients with TBI. In addition, an objective meridian instrument analysis was added to analyze the energy distribution in the meridian of TBI patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2021
CompletedFirst Submitted
Initial submission to the registry
June 9, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2024
CompletedJune 21, 2021
June 1, 2021
3 years
June 9, 2021
June 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
GCS(Glasgow Coma Scale)
To assess the recovery of consciousness. Lower GCS scores are correlated with higher risk of death.
4 weeks
Barthel index
To assess the activities of daily life.
4 weeks
Muscle power
To assess the recovery of muscle power.
4 weeks
mGOS(Modified Glasgow Outcome Score)
To assess the neurological outcomes, score 1 to 5. the higher the score, the better outcome.
4 weeks
RTS (Revised Trauma Score)
To assess the physiologic condition of patients. The Revised Trauma Score is made up of a three categories: Glasgow Coma Scale, systolic blood pressure, and respiratory rate. The score range is 0-12. A lower score indicates a higher severity of injury.
4 weeks
Secondary Outcomes (1)
Meridian energy assessment
4 weeks
Study Arms (4)
Intervention group (Severe)
EXPERIMENTALA patient's Glasgow Coma Score (GCS) between 5-8 1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments. 2. Evaluating the meridian energy by M.E.A.D
Control group (Severe)
NO INTERVENTIONA patient's Glasgow Coma Score (GCS) between 5-8 1. Conventional treatment. 2. Evaluating the meridian energy by M.E.A.D
Intervention group (Moderate)
EXPERIMENTALA patient's Glasgow Coma Score (GCS) between 9-13 1. Conventional treatment and bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments. 2. Evaluating the meridian energy by M.E.A.D
Control group (moderate)
NO INTERVENTIONA patient's Glasgow Coma Score (GCS) between 9-13 1. Conventional treatment. 2. Evaluating the meridian energy by M.E.A.D
Interventions
bloodletting at the well points of both hands and feet and acupuncture in DU26, DU24 3 times per week for 4 weeks, total 12 treatments.
Eligibility Criteria
You may qualify if:
- Patient with moderate to severe head injury are admitted to the ICU (Intensive Care Unit). patient with stable vital sign and the GCS (Glasgow coma volume) between 5-13 will be included.
- Patient with normal consciousness and no cognitive or motor function disease before brain injury.
- Patient aged between 20 to 80 years old and is willing to sign the consent (the agent can sign on behalf of patient).
You may not qualify if:
- Patients who are vital sign unstable and with severe complication.
- Patients combined with other terminal illness such as cancer in terminal stage, liver failure, end stage renal failure and so on.
- Pregnant patients.
- Any other conditions deemed unsuitable by the physician in charge.
- Patients (agent of the patient) who did not sign the consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
wei Ling Chou
Chang Gung Medical Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 18, 2021
Study Start
June 8, 2021
Primary Completion
June 7, 2024
Study Completion
June 7, 2024
Last Updated
June 21, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share